A new, automatic capsule filling system produced by Italian manufacturer MultiPharma is now available exclusively in the UK from Glenvale Packaging.
The MultiPharma V10 system is the first new machine to be introduced into the UK since Northamptonshire-based Glenvale Packaging was appointed to distribute MultiPharma’s products.
The totally enclosed V10 system is suitable for handling potent products and can process up to 9,000 capsules/hr. It has a footprint of 90x110cm and, owing to fitted castors, can be moved around a production facility.
‘The design is ideal for handling hard shell capsules – both gelatine and vegetarian options,’ said Garry Coleman, partner at Glenvale Packaging.
‘It is supplied fully specified to handle the desired capsule size. Additional accessories can then also be fitted to accommodate size changes as needed.’
The unit only requires air and electrical connections and is operated by a touchscreen that can be positioned to suit the operator’s needs. The anodised, aluminium construction meets GMP regulatory requirements.
‘The V10 has already been proven in Europe,’ added Coleman. ‘It is suited to a range of applications – from clinical trials in the health industry through to small manufacturing operations.’
Glenvale Packaging introduces MultiPharma V10 in the UK
An automatic capsule filling machine that handles potent products
You may also like
Trending Articles
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months